Matrix-degrading proteases and angiogenesis during development and tumor formation

APMIS

Volumn 107, Issue 1, 1999, Pages 11-18

  Werb, Zena ^a   Vu, Thiennu H ^a   Rinkenberger, Julie L ^a   Coussens, Lisa M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Apoptosis; Bone; Ets 2; Hypertrophic cartilage; Implantation; Matrix metalloproteinases; MMP 9; Skin; Squamous cell carcinoma; Trophoblast; VEG

Indexed keywords

MATRIX METALLOPROTEINASE;

ANGIOGENESIS; ANIMAL TISSUE; BONE DEVELOPMENT; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; METASTASIS POTENTIAL; MOUSE; NIDATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION;

EID: 0033067863     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01521.x     Document Type: Review

References (28)

1. 1. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997;91:439-42.
2. 2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
3. 3. Rinkenberger JL, Cross JC, Werb Z. Molecular genetics of implantation in the mouse. Dev Genetics 1997;21:6-20.
4. 4. Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: Key pieces of the development puzzle. Science 1994;266:1508-18.
5. 5. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP, Werb Z. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996;122:1723-36.
6. 6. Roberts JM, Taylor RN; Friedman SA. New Developments in Preeclampsia. London: Edward Arnold Publishers: 1993.
7. 7. Gilabèrt J, Estelles A, Grancha S, Espana F, Aznar J. Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia. Hum Reprod 1995; 10 (Suppl. 2): 121-31.
8. 8. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419-24.
9. 9. Yamamoto H, Flannery ML, Kupriyanov S, Pearce J, McKercher SR, Henkel GW, et al. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev 1998;12:1315-26.
10. 10. Vu TH, Shipley JM; Bergers G, Berger JE, Helms JA, Hanahan D, et al. MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998;93:411-22.
11. 11. Reponen P, Sahlber C, Munauat C, Thesleff I, Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 1994;124:1091-102.
12. 12. Noden D. Cell movements and control of patterned tissue assembly during craniofacial development. J Craniofac Genet Dev Biol 1991;11:192-213.
13. 13. Frommer J, Margolis MR. Contribution of Meckel's cartilage to ossification of the mandible in mice. J Dent Res 1971;50:1260-7.
14. 14. Chin JR, Werb Z. Matrix metalloproteinases regulate migration, invasion and morphogenesis in epithelium, skeletal muscle and cartilage of the mandibular arch. Dev 1997;124:1519-30.
15. 15. Flenniken AM, Williams BRG. Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice. Genes Dev 1990;4:1094-106.
16. 16. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuk T, Itohar S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 1997;272:22389-92.
17. 17. McClearn D, Medville R, Noden D. Muscle cell death during development of head and nack muscles in the chick embryo. Dev Dynamics 1995;202:365-77.
18. 18. Noden D. Origins and patterning of craniofacial mesenchymal tissues. J Craniofac Genet Dev Biol 1986;2: 15-31.
19. 19. Coussens LM, Werb Z. Matrix metalloproteinase expression and neoplasia. Chemistry & Biology 1996;3: 895-904.
20. 20. Arbeit J, Münger K, Howley P, Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 1994;68:358-68.
21. 21. Coussens LM, Hanahan D, Arbeit J. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 1996; 149:1899-917.
22. 22. Ingber DE, Folkman J. How does extracellular matrix control capillary morphogenesis? Cell 1989;58:803-5.
23. 23. Smith-McCune K, Zhu Y-H, Hanahan D, Arbeit J. Angiogenesis and VEGF mRNA upregulation in progressive epithelial neoplasias caused by human papillomaviruses: Cross-species comparison of human cervical cancer and a transgenic mouse model. Cancer Res 1996;57:1294-300.
24. 24. Coussens LM, Raymond WW, Bergers G, Behrendtsen O, Werb Z, Caughey GH, et al. Inflammatory mast cells potentiate the angiogenic switch during squamous epithelial carcinogenesis. 1998. Submitted for publication.
25. 25. Liu Z, Shipley JM, Vu TH, Zhou X, Diaz LA, Werb Z, et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 1998;188:475-82.
26. 26. Bergers G, Hanahan D, Coussens LM. Angiogeneis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol 1998: In press.
27. 27. Iruela-Arispe M, Dvorak H. Angiogenesis: a dynamic balance of stimulators and inhibitors. Thrombosis and Haemostasis 1997;78:672-7.
28. 28. Vlodavsky I, Miao H-Q, Medalion B, Danagher P, Ron D. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer and Metastasis Reviews 1996;15:177-86.